Shenzhen University General Hospital

This study tests a new treatment for people with certain blood cancers (like lymphoma or leukemia) that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better find and attack cancer cells. The go…

This study tests a new type of cell therapy (CD19/CD20 CAR/TRuC-T) in 20 adults with B-cell lymphoma that has returned or not responded to treatment. Participants receive chemotherapy followed by an infusion of their own modified immune cells. The goal is to control the disease a…

This study tests a treatment called MSLN CAR-T, which uses a patient's own immune cells modified to attack tumors that have a specific marker (MSLN). It is for adults with advanced solid tumors that cannot be removed by surgery. Participants receive chemotherapy before the cell i…

This study tests a combination of three drugs (bugitinib, venetoclax, and cytarabine) in adults with acute myeloid leukemia that has come back or not responded to treatment. The goal is to see if the combo can wipe out hidden cancer cells and keep them away. About 10 participants…